Repisalud
Publication
Artículo científico (JournalArticle)
Excessive glycosylation drives thoracic aortic aneurysm formation through integrated stress response.
Thoracic aortic aneurysms and dissections (TAADs) are depicted by aortic medial degeneration characterized by glycan-rich matrix accumulation. Marfan syndrome (MFS) is the most common inherited connective tissue disorder associated with TAAD. Although vascular smooth muscle cell metabolic dysfunction has emerged as a pathogenic driver of TAAD, surgical repair remains the mainstay of treatment. This study aimed to investigate the role of the hexosamine biosynthetic pathway (HBP) in sporadic and genetic TAAD pathophysiology. Hexosamine biosynthetic pathway activation was analysed in aortas from an MFS mouse model, a β-aminopropionitrile-induced non-genetic TAAD model, and patients with sporadic TAAD using transcriptomic and metabolomic approaches. Aortic dilatation was monitored by ultrasound imaging. Pharmacological inhibition of HBP and integrated stress response (ISR) was performed to assess their therapeutic potential. Hexosamine biosynthetic pathway was up-regulated in both an MFS mouse model and β-aminopropionitrile-induced TAAD, as well as in aortic samples from MFS and sporadic TAAD patients. Enhanced HBP activity contributed to aortic dilatation and medial degeneration via vascular smooth muscle cell dysfunction and ISR activation. Inhibition of HBP or ISR reversed these effects in the MFS model. The HBP-ISR axis drives medial degeneration in TAAD. These findings identify HBP and ISR as a potential target in TAAD of both genetic and non-genetic origin.
Project:
European Commission / Horizon 2020 Framework Programme ERC-2021-CoG-101044248-LetTBe
,
ES / RYC2021-033343-I Not available
,
ES / PID2022-137730OA-I00 Not available
,
ES / MCIN AEI
,
ES / PID2022-141169OB-I00 Not available
,
ES / PID2022-138295OB-I00 Not available
,
ES / PI20 01103
,
ES / PI23 00100
,
ES / CP22 00100
,
ES / PID2022-136979OBI00 Not available
,
ES / PI22 00233
,
ES / PI20 00923
,
ES / PI21 00084
,
ES / PI21 0112
,
ES / FIS22 00140
,
ES / HR18-00068 Not available
,
ES / PID2021-122388OB-100 Not available
,
ES / MCIN AEI
,
ES / CIBER-CV CB16 11
,
ES / MICIN AEI